Brief: Repare Therapeutics Q3 EPS USD -0.81
07/11/2024 12:05
Nov 07 (Reuters) - Repare Therapeutics Q3 net income USD -34.406 million. * Q3 operating expenses USD 36.372 million * Q3 income from operations USD -36.372 million * Q3 pretax profit USD -33.921 million
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln